Main Street Financial Solutions »

Protalix Biotherapeutics shares owned by Main Street Financial Solutions

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Main Street Financial Solutions from 13F filings

Historical chart of Main Street Financial Solutions investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Main Street Financial Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Main Street Financial Solutions

Quarter filed Position value Share count Share price at filing
2025-09-30 $287k 129k 2.22

More positions owned by Main Street Financial Solutions

Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Dividend Eq (SCHD)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Navios Maritime Partners Com Unit Lpi (NMM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)

View all positions for Main Street Financial Solutions

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
Stratos Wealth Partners
State Street Corporation
Vanguard Group
Morgan Stanley
Connor, Clark & Lunn Investment Management
UBS Group
Bridgeway Capital Management
Diametric Capital
Charles Schwab Investment Management
Commonwealth Equity Services

View all funds holding Protalix Biotherapeutics